Literature DB >> 30667555

Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.

Nadja Fratzl-Zelman1, Paul Roschger1, Heeseog Kang2, Smita Jha3,4, Andreas Roschger5, Stéphane Blouin1, Zuoming Deng6, Wayne A Cabral2, Aleksandra Ivovic7, James Katz8, Richard M Siegel7, Klaus Klaushofer1, Peter Fratzl5, Timothy Bhattacharyya3, Joan C Marini2.   

Abstract

Melorheostosis is a rare non-hereditary condition characterized by dense hyperostotic lesions with radiographic "dripping candle wax" appearance. Somatic activating mutations in MAP2K1 have recently been identified as a cause of melorheostosis. However, little is known about the development, composition, structure, and mechanical properties of the bone lesions. We performed a multi-method phenotype characterization of material properties in affected and unaffected bone biopsy samples from six melorheostosis patients with MAP2K1 mutations. On standard histology, lesions show a zone with intensively remodeled osteonal-like structure and prominent osteoid accumulation, covered by a shell formed through bone apposition, consisting of compact multi-layered lamellae oriented parallel to the periosteal surface and devoid of osteoid. Compared with unaffected bone, melorheostotic bone has lower average mineralization density measured by quantitative backscattered electron imaging (CaMean: -4.5%, p = 0.04). The lamellar portion of the lesion is even less mineralized, possibly because the newly deposited material has younger tissue age. Affected bone has higher porosity by micro-CT, due to increased tissue vascularity and elevated 2D-microporosity (osteocyte lacunar porosity: +39%, p = 0.01) determined on quantitative backscattered electron images. Furthermore, nano-indentation modulus characterizing material hardness and stiffness was strictly dependent on tissue mineralization (correlation with typical calcium concentration, CaPeak: r = 0.8984, p = 0.0150, and r = 0.9788, p = 0.0007, respectively) in both affected and unaffected bone, indicating that the surgical hardness of melorheostotic lesions results from their lamellar structure. The results suggest a model for pathophysiology of melorheostosis caused by somatic activating mutations in MAP2K1, in which the genetically induced gradual deterioration of bone microarchitecture triggers a periosteal reaction, similar to the process found to occur after bone infection or local trauma, and leads to an overall cortical outgrowth. The micromechanical properties of the lesions reflect their structural heterogeneity and correlate with local variations in mineral content, tissue age, and remodeling rates, in the same way as normal bone.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE BIOPSIES; HISTOLOGY; MELORHEOSTOSIS; MICRO-CT; NANOINDENTATION; QUANTITATIVE BACKSCATTERED ELECTRON IMAGING (qBEI)

Mesh:

Substances:

Year:  2019        PMID: 30667555      PMCID: PMC8302214          DOI: 10.1002/jbmr.3656

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  44 in total

1.  Normative data for iliac bone histomorphometry in growing children.

Authors:  F H Glorieux; R Travers; A Taylor; J R Bowen; F Rauch; M Norman; A M Parfitt
Journal:  Bone       Date:  2000-02       Impact factor: 4.398

Review 2.  Caffey disease: new perspectives on old questions.

Authors:  Harikiran Nistala; Outi Mäkitie; Harald Jüppner
Journal:  Bone       Date:  2013-12-31       Impact factor: 4.398

3.  ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis.

Authors:  Georgia Mavria; Yvonne Vercoulen; Maggie Yeo; Hugh Paterson; Maria Karasarides; Richard Marais; Demelza Bird; Christopher J Marshall
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 31.743

4.  Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts.

Authors:  Natalie A Sims; Christina Vrahnas
Journal:  Arch Biochem Biophys       Date:  2014-05-26       Impact factor: 4.013

5.  Primary bone microanatomy records developmental aspects of life history in catarrhine primates.

Authors:  Shannon C McFarlin; Carl J Terranova; Adrienne L Zihlman; Timothy G Bromage
Journal:  J Hum Evol       Date:  2016-03-10       Impact factor: 3.895

6.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

7.  The bone mineralization density distribution as a fingerprint of the mineralization process.

Authors:  D Ruffoni; P Fratzl; P Roschger; K Klaushofer; R Weinkamer
Journal:  Bone       Date:  2007-01-25       Impact factor: 4.398

Review 8.  Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.

Authors:  Nadja Fratzl-Zelman; Angelika Valenta; Paul Roschger; Alexander Nader; Bruce D Gelb; Peter Fratzl; Klaus Klaushofer
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

Review 9.  Sclerosing bone disorders.

Authors:  Marie-Christine de Vernejoul
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 10.  Fragility of Bone Material Controlled by Internal Interfaces.

Authors:  Wolfgang Wagermaier; Klaus Klaushofer; Peter Fratzl
Journal:  Calcif Tissue Int       Date:  2015-03-14       Impact factor: 4.333

View more
  6 in total

1.  Melorheostosis: A Clinical, Pathologic, and Radiologic Case Series.

Authors:  Cameron N Fick; Nadja Fratzl-Zelman; Paul Roschger; Klaus Klaushofer; Smita Jha; Joan C Marini; Timothy Bhattacharyya
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

2.  50 years of scanning electron microscopy of bone-a comprehensive overview of the important discoveries made and insights gained into bone material properties in health, disease, and taphonomy.

Authors:  Furqan A Shah; Krisztina Ruscsák; Anders Palmquist
Journal:  Bone Res       Date:  2019-05-22       Impact factor: 13.567

3.  Clinical Evaluation of Melorheostosis in the Context of a Natural History Clinical Study.

Authors:  Smita Jha; Edward W Cowen; Tanya J Lehky; Katharine Alter; Lauren Flynn; James C Reynolds; Eileen Lange; James D Katz; Joan C Marini; Richard M Siegel; Timothy Bhattacharyya
Journal:  JBMR Plus       Date:  2019-07-26

4.  Clinical characteristics of 10 Chinese patients with melorheostosis and identification of a somatic MAP2K1 variant in one case.

Authors:  Xiaojun Han; Yang Xu; Zhanying Wei; Chun Wang; Hua Yue; Zhenlin Zhang
Journal:  Mol Genet Genomic Med       Date:  2022-08-25       Impact factor: 2.473

5.  Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.

Authors:  Heeseog Kang; Smita Jha; Aleksandra Ivovic; Nadja Fratzl-Zelman; Zuoming Deng; Apratim Mitra; Wayne A Cabral; Eric P Hanson; Eileen Lange; Edward W Cowen; James Katz; Paul Roschger; Klaus Klaushofer; Ryan K Dale; Richard M Siegel; Timothy Bhattacharyya; Joan C Marini
Journal:  J Exp Med       Date:  2020-05-04       Impact factor: 14.307

Review 6.  High Fidelity of Mouse Models Mimicking Human Genetic Skeletal Disorders.

Authors:  Robert Brommage; Claes Ohlsson
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.